A carregar...
Workup and Management of Immune‐Mediated Colitis in Patients Treated with Immune Checkpoint Inhibitors
As the use of immune checkpoint inhibitors for several different malignancies becomes more mainstream, their side‐effect profile raises new challenges. In 2011, the Food and Drug Administration approved the first checkpoint inhibitor for the treatment of advanced melanoma, and since then, checkpoint...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7066712/ https://ncbi.nlm.nih.gov/pubmed/32162824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0304 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|